HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recent developments in the management of severe asthma.

Abstract
Fevipiprant is unlikely to be implemented as a future treatment for severe asthma, while tezepelumab may be a future treatment option for patients with severe asthma with and without eosinophilic inflammation https://bit.ly/3KE1BH4.
AuthorsHowraman Meteran, Louise Lindhardt Tønnesen, Pradeesh Sivapalan, Truls Sylvan Ingebrigtsen, Jens-Ulrik Stæhr Jensen
JournalBreathe (Sheffield, England) (Breathe (Sheff)) Vol. 18 Issue 1 Pg. 210178 (Mar 2022) ISSN: 1810-6838 [Print] England
PMID36338257 (Publication Type: Journal Article)
CopyrightCopyright ©ERS 2022.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: